Search

Your search keyword '"Soong BW"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Soong BW" Remove constraint Author: "Soong BW" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
61 results on '"Soong BW"'

Search Results

1. MRl and MRS hints for the differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia type II.

2. Progressive macular ischemia in retinal vasculopathy with cerebral leukodystrophy.

Catalog

Books, media, physical & digital resources

3. Scale for Ocular motor Disorders in Ataxia (SODA).

5. COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition.

6. Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia.

8. A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

9. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.

10. Investigating TBP CAG/CAA trinucleotide repeat expansions in a Taiwanese cohort with ALS.

11. Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.

12. Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan.

13. Novel KCND3 Variant Underlying Nonprogressive Congenital Ataxia or SCA19/22 Disrupt K V 4.3 Protein Expression and K+ Currents with Variable Effects on Channel Properties.

14. Clinical and Genetic Characterization of Autosomal Recessive Spinocerebellar Ataxia Type 16 (SCAR16) in Taiwan.

15. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.

16. Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force.

17. Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.

18. Supratentorial and Infratentorial Lesions in Spinocerebellar Ataxia Type 3.

19. Diffusion Tensor Magnetic Resonance Imaging for Differentiating Multiple System Atrophy Cerebellar Type and Spinocerebellar Ataxia Type 3.

20. The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force.

21. Novel SCA19/22-associated KCND3 mutations disrupt human K V 4.3 protein biosynthesis and channel gating.

22. Treadmill training increases the motor activity and neuron survival of the cerebellum in a mouse model of spinocerebellar ataxia type 1.

23. Xenografting of human umbilical mesenchymal stem cells from Wharton's jelly ameliorates mouse spinocerebellar ataxia type 1.

24. Investigating PUM1 mutations in a Taiwanese cohort with cerebellar ataxia.

25. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.

26. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.

27. Intra- and Inter-Modular Connectivity Alterations in the Brain Structural Network of Spinocerebellar Ataxia Type 3.

28. Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology.

29. Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin.

30. Impaired Efficiency and Resilience of Structural Network in Spinocerebellar Ataxia Type 3.

31. Genetic analysis of ANXA11 variants in a Han Chinese cohort with amyotrophic lateral sclerosis in Taiwan.

32. Mutational analysis of CCM1, CCM2 and CCM3 in a Han Chinese cohort with multiple cerebral cavernous malformations in Taiwan.

33. Characterization of Heterozygous HTRA1 Mutations in Taiwanese Patients With Cerebral Small Vessel Disease.

34. A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3.

36. Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis.

37. Spinocerebellar ataxias.

38. Mutational analysis of ITPR1 in a Taiwanese cohort with cerebellar ataxias.

39. A novel DNAJB6 mutation causes dominantly inherited distal-onset myopathy and compromises DNAJB6 function.

40. Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia.

41. A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathy.

42. Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.

43. The involvement of supratentorial white matter in multiple system atrophy: a diffusion tensor imaging tractography study.

44. ATXN2 trinucleotide repeat length correlates with risk of ALS.

45. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.

46. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.

47. Clinical and biophysical characterization of 19 GJB1 mutations.

48. PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects.

49. Spinocerebellar ataxia type 36 in the Han Chinese.

50. Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis.